Richard Foster

6.4k total citations
97 papers, 2.4k citations indexed

About

Richard Foster is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Richard Foster has authored 97 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 33 papers in Genetics and 15 papers in Surgery. Recurrent topics in Richard Foster's work include Neurogenetic and Muscular Disorders Research (28 papers), RNA modifications and cancer (16 papers) and Ion Channels and Receptors (8 papers). Richard Foster is often cited by papers focused on Neurogenetic and Muscular Disorders Research (28 papers), RNA modifications and cancer (16 papers) and Ion Channels and Receptors (8 papers). Richard Foster collaborates with scholars based in United Kingdom, United States and Italy. Richard Foster's co-authors include David J. Beech, Sheena E. Radford, Charlotte Revill, Lydia Young, Janet C. Saunders, Alison E. Ashcroft, Rachel Mahood, Colin W. G. Fishwick, Melanie J. Ludlow and Kevin Cuthbertson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Richard Foster

92 papers receiving 2.4k citations

Peers

Richard Foster

PHYSI

SURGE

GENET

PRM

Hidehito Kotani Japan

Ching-Shih Chen United States

William L. Dean United States

Rebecca P. Hughey United States

Thomas Rückle Switzerland

Mike A. Clark United States

Elena Tibaldi Italy

Bruno Ségui France

Kenichi Higashino Japan

Susan H. Garfield United States

Hidehito Kotani Japan

Richard Foster

1.9k ×1.5

562 ×0.8

PHYSI

226 ×0.6

SURGE

117 ×0.3

GENET

218 ×0.8

PRM

Citations per year, relative to Richard Foster Richard Foster (= 1×) peers Hidehito Kotani

Countries citing papers authored by Richard Foster

Since Specialization

Citations

This map shows the geographic impact of Richard Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Foster more than expected).

Fields of papers citing papers by Richard Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Foster. The network helps show where Richard Foster may publish in the future.

Co-authorship network of co-authors of Richard Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Foster. A scholar is included among the top collaborators of Richard Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Foster. Richard Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Proud, Crystal M., Richard S. Finkel, Julie Parsons, et al.. (2025). Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy. Journal of Clinical Investigation. 135(22). 1 indexed citations

Chuntharpursat‐Bon, Eulashini, Oleksandr V. Povstyan, Marjolaine Debant, et al.. (2025). Regulation of PIEZO1 channel force sensitivity by interblade handshaking. Science Advances. 11(24). eadt7046–eadt7046. 3 indexed citations

Leonardo, Trevor R., et al.. (2025). The Streptococcus pyogenes Rgg2/Rgg3 quorum sensing system causes global suppression of macrophage inflammatory programs via an intranuclear mechanism. mBio. 16(11). e0037325–e0037325.

Xu, Yong, Martin Wilkinson, Anastasia Zhuravleva, et al.. (2025). Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes Drug. Journal of the American Chemical Society. 147(14). 11859–11878. 3 indexed citations

Hemmings, Karen E., et al.. (2024). Side-by-side comparison of published small molecule inhibitors against thapsigargin-induced store-operated Ca2+ entry in HEK293 cells. PLoS ONE. 19(1). e0296065–e0296065. 1 indexed citations

Endesh, Naima, Eulashini Chuntharpursat‐Bon, Charlotte Revill, et al.. (2023). Independent endothelial functions of PIEZO1 and TRPV4 in hepatic portal vein and predominance of PIEZO1 in mechanical and osmotic stress. Liver International. 43(9). 2026–2038. 20 indexed citations

Parsons, Julie, John F. Brandsema, Crystal M. Proud, et al.. (2023). P210 Interim results from the RESPOND study evaluating nusinersen in children with spinal muscular atrophy previously treated with onasemnogene abeparvovec. Neuromuscular Disorders. 33. S87–S87. 2 indexed citations

Hethershaw, Emma, Majid Ali, Richard Foster, et al.. (2023). Glycated albumin modulates the contact system with implications for the kallikrein-kinin and intrinsic coagulation systems. Journal of Thrombosis and Haemostasis. 21(4). 814–827. 3 indexed citations

Foster, Holly, Clare Wilson, Julia S. Gauer, et al.. (2022). A Comparative Assessment Study of Known Small-molecule GPVI Modulators. ACS Medicinal Chemistry Letters. 13(2). 171–181. 6 indexed citations

10.

Lü, Bo, Richard Foster, Yiwei Zhang, et al.. (2022). Matching design for augmenting the control arm of a randomized controlled trial using real-world data. Journal of Biopharmaceutical Statistics. 32(1). 124–140. 7 indexed citations

11.

Wilson, Clare, et al.. (2022). Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation. Research and Practice in Thrombosis and Haemostasis. 6(4). e12715–e12715. 5 indexed citations

12.

Kearney, Katherine J., Clare Wilson, Majid Ali, et al.. (2021). Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI. Proceedings of the National Academy of Sciences. 118(3). 46 indexed citations

13.

Darras, Basil T., Darryl C. De Vivo, Michelle A. Farrar, et al.. (2020). Safety Profile of Nusinersen in Presymptomatic and Infantile-Onset Spinal Muscular Atrophy (SMA): Interim Results From the NURTURE and ENDEAR-SHINE Studies (1659). Neurology. 94(15_supplement). 4 indexed citations

14.

Blythe, Nicola M., Katsuhiko Muraki, Melanie J. Ludlow, et al.. (2019). Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion. Journal of Biological Chemistry. 294(46). 17395–17408. 127 indexed citations

15.

Mughal, Romana, Asjad Visnagri, Kevin Cuthbertson, et al.. (2019). Piezo1 channel activation mimics high glucose as a stimulator of insulin release. Scientific Reports. 9(1). 16876–16876. 42 indexed citations

16.

Montes, Jacqueline, Sally Dunaway Young, Elena Mazzone, et al.. (2018). Ambulatory function and fatigue in nusinersen-treated children with spinal muscular atrophy. (P2.322). Neurology. 90(15_supplement). 4 indexed citations

17.

Robinson, James, Euan W. Baxter, Robin L. Owen, et al.. (2017). Affimer proteins inhibit immune complex binding to FcγRIIIa with high specificity through competitive and allosteric modes of action. Proceedings of the National Academy of Sciences. 115(1). E72–E81. 33 indexed citations

18.

Muraki, Katsuhiko, Hiroka Suzuki, Noriyuki Hatano, et al.. (2017). Na+ entry through heteromeric TRPC4/C1 channels mediates (−)Englerin A-induced cytotoxicity in synovial sarcoma cells. Scientific Reports. 7(1). 16988–16988. 32 indexed citations

19.

Foster, Toshana L., Gary S. Thompson, Arnout P. Kalverda, et al.. (2013). Structure-Guided Design Affirms Inhibitors of Hepatitis C Virus p7 as a Viable Class of Antivirals Targeting Virion Release. Hepatology. 59(2). 408–422. 48 indexed citations

20.

Foster, Toshana L., Ann L. Wozniak, Matthew Bentham, et al.. (2011). Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel. Hepatology. 54(1). 79–90. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact